Min. Investment$250
IndustryBiotech
Do you think Ajna Biosciences is a good investment?
YES
NO
AJNA BioSciences is on a mission to revolutionize the $678 billion US pharmaceutical industry with botanical drugs. Powered by leading scientists from Harvard, Johns Hopkins, and NYU, AJNA is pioneering a new regulatory pathway to develop FDA-approved drugs from plant medicine. Leveraging proven medicinal compounds from nature, our first two drug candidates treat conditions more than 80 million people suffer from today: Autism Spectrum Disorder and Generalized Anxiety Disorder. Our third candidate is a full spectrum THC drug to treat PTSD and it is in strain selection currently.
Terms
Min. Investment$250
IndustryBiotech
Target Raise$1,200,000
Close DateAugust 31, 2024
SUBSCRIBE TO BENZINGA ALT RATINGS
Benzinga is launching an alternative asset rating product. Enter your email above to receive emails on new ratings.
Offering Disclosure
Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see disclosures linked in the campaign page for more information.
What is the target raise?
Target raise is $1,200,000
What is the minimum investment amount?
Min. investment is $250
